VCP anticorps (AA 10-512)
Aperçu rapide pour VCP anticorps (AA 10-512) (ABIN7826030)
Antigène
Voir toutes VCP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 10-512
-
Fonction
- Anti-Zebrafish VCP Antibody
-
Attributs du produit
- Anti-Zebrafish VCP Antibody catalog # AZQ7ZU99. Tested in WB, IHC applications. This antibody reacts with Zebrafish. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived zebrafish VCP recombinant protein (Position: D10-K512).
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Western blot, 0.25-0.5 μg/mL, Zebrafish
Immunohistochemistry, 2-5 μg/mL, Zebrafish
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
-
- VCP (Valosin Containing Protein (VCP))
-
Autre désignation
- VCP
-
Sujet
- Predicted to enable ATP hydrolysis activity and polyubiquitin modification-dependent protein binding activity. Acts upstream of or within several processes, including heart contraction, regulation of catabolic process, and striated muscle cell development. Predicted to be located in cytoplasm and site of double-strand break. Predicted to be part of VCP-NPL4-UFD1 AAA ATPase complex. Predicted to be active in cytosol and nucleus. Is expressed in several structures, including brain, digestive system, eye, fin bud, and trunk musculature. Human ortholog(s) of this gene implicated in several diseases, including Charcot-Marie-Tooth disease type 2Y, Paget's disease of bone, frontotemporal dementia and/or amyotrophic lateral sclerosis 6, inclusion body myopathy with early-onset Paget disease of bone with or without frontotemporal dementia 1, and inclusion body myositis. Orthologous to human VCP (valosin containing protein).
-
Poids moléculaire
- 97 kDa
-
Pathways
- ER-Nucleus Signaling, Positive Regulation of Endopeptidase Activity, Ubiquitin Proteasome Pathway
Antigène
-